Prenatal STI Screening Twice During Pregnancy Cuts Preterm Birth Risk by 23%
A clinical trial found that twice-per-pregnancy STI screening reduced preterm birth risk by 23% versus standard care.
A clinical trial found that twice-per-pregnancy STI screening reduced preterm birth risk by 23% versus standard care.
The HIV self-test has received Health Canada approval, making it the first oral HIV self-test available in Canada. Results are provided in 20 minutes with an oral swab.
Labcorp is introducing FDA-approved self-collection solutions for HPV and STI testing, offering a convenient and private option for screening.
Labcorp has expanded its STI testing options with an FDA-authorized OTC blood test for syphilis that provides rapid results.
Read MoreMpox was beaten back just to reemerge with a more virulent, deadly variant. Diagnostic testing is critical in fighting the disease.
Read MoreThe World Health Organization (WHO) listed Abbott’s Alinity m MPXV assay as the first mpox IVD under its Emergency Use Listing procedure.
Read MoreAn emergency department dramatically increased screening and diagnosis rates for syphilis by offering optional tests for the STI.
Read MoreThe NIAID has awarded grants for 10 projects aimed at developing advanced diagnostic tools for congenital and adult syphilis.
Read MoreWHO invited manufacturers of mpox IVDs to submit expressions of interest for Emergency Use Listing in response to rising cases in Africa.
Read MoreQuidelOrtho received FDA 510(k) clearance for its VITROS syphilis assay, expanding its test portfolio to address the syphilis epidemic.
Read MoreEurofins has launched the Mplex Mpox, Orthopox real-time PCR assay for the qualitative detection and differentiation of the mpox virus.
Read MoreVirax Biolabs secured a distribution agreement to commercialize Mpox detection kits across Europe and for Gulf Cooperation Council nations.
Read MoreSeegene Inc. has developed new PCR test assays to detect mpox aimed at aiding in global research and diagnostics efforts.
Read MoreThe FDA granted marketing authorization to NOWDiagnostics for its syphilis test, the first OTC at-home test to detect syphilis antibodies.
Read MoreA study highlights significant gaps in adherence to guideline-based testing and treatment for chlamydia and gonorrhea for pregnant women.
Read MoreA study by FAIR Health reveals a 4.8 percent increase in STD diagnoses among commercially insured patients from 2020 to 2023.
Read MoreResearchers developed a new lab test to detect intact HIV infections with African strains, crucial for advancing global HIV cure efforts.
Read MoreSyphilis cases are rising globally, yet many Americans remain unaware of its symptoms and treatment options.
Read More